IOL Chemicals and Pharmaceuticals Balance Sheet
- Market cap
- ₹5,996 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹147.07 – ₹275.76
As of FY25, IOL Chemicals and Pharmaceuticals had total assets of ₹3,897 crore and borrowings of ₹720 crore, against shareholders' equity of ₹2,818 crore — a debt-to-equity ratio of 0.35.
IOL Chemicals and Pharmaceuticals balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 2,698 |
| Borrowings | 720 |
| Other liabilities | 480 |
| Total liabilities | 3,897 |
| Fixed assets | 2,099 |
| Capital work in progress | 45 |
| Investments | 899 |
| Other assets | 899 |
| Total assets | 3,897 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹71.67
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
IOL Chemicals and Pharmaceuticals balance sheet — frequently asked questions
What is the total debt of IOL Chemicals and Pharmaceuticals?
IOL Chemicals and Pharmaceuticals reported borrowings of ₹720 crore as of FY25.
What is IOL Chemicals and Pharmaceuticals' debt-to-equity ratio?
Based on the FY25 balance sheet, IOL Chemicals and Pharmaceuticals' debt-to-equity ratio is 0.35 — borrowings of ₹720 crore against equity capital and reserves of ₹2,818 crore.
What are IOL Chemicals and Pharmaceuticals' total assets?
IOL Chemicals and Pharmaceuticals' total assets were ₹3,897 crore as of FY25, including fixed assets of ₹2,099 crore and investments of ₹899 crore.
What is the book value per share of IOL Chemicals and Pharmaceuticals?
The book value per share of IOL Chemicals and Pharmaceuticals is ₹71.67, based on the latest reported balance sheet.
Same Data For Peers
Trade IOL Chemicals and Pharmaceuticals With ATS
Track IOLCP live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.